The debate over drug pricing and what the government can and should do about it is heating up. It tends to heat up ahead of elections, and with the mid-terms in November, we’re going through the cycle once again, sparked by provisions in the Inflation Reduction Act.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,